Today's bump comes following the company's announcement that the FDA had approved its da Vinci Xi surgical system.
Must Read: Warren Buffett's 10 Favorite Stocks
The company describes the robotic surgical system as "a technological leap forward in replacing large-incision abdominal surgeries (open surgery) with a minimally invasive approach."
"The da Vinci Xi System's new overhead architecture means that multi-quadrant surgery can be performed without repositioning the system, an innovation long sought by surgeons who perform complex procedures. We strive to provide the most advanced, least invasive option for surgery, and we are working hard to make minimally invasive surgery the standard of care," said Gary Guthart, company'president and CEO.
Having won approval from U.S. regulators, the company now plans to seek clearance to market the technology worldwide.